XML 19 R4.htm IDEA: XBRL DOCUMENT v3.10.0.1
Consolidated Statements of Earnings - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Revenue      
Total revenue $ 408,897 $ 302,238 $ 215,003
Costs and expenses      
Cost of product sales 15,356 15,215 11,986
Research and development 89,209 49,577 42,791
Selling, general and administrative 159,888 137,905 106,010
Total costs and expenses 264,453 202,697 160,787
Operating earnings 144,444 99,541 54,216
Other income (expense)      
Interest income 13,843 2,864 1,467
Interest expense (13,840) (134) (543)
Interest expense on non-recourse liability related to sale of future royalties (4,271) (1,434) (4,548)
Changes in fair value of derivative liabilities   76 448
Loss on extinguishment of debt   (295) (671)
Total other income (expense) (4,268) 1,077 (3,847)
Earnings before income taxes 140,176 100,618 50,369
Income tax expense (benefit) 29,183 43,334 (40,852)
Net earnings $ 110,993 $ 57,284 $ 91,221
Earnings per share:      
Basic (in dollars per share) $ 2.13 $ 1.13 $ 1.84
Diluted (in dollars per share) $ 2.05 $ 1.08 $ 1.76
Weighted-average shares outstanding:      
Basic (in shares) 51,989,824 50,756,603 49,472,434
Diluted (in shares) 54,098,872 53,301,150 51,708,983
Product      
Revenue      
Total revenue $ 399,871 $ 294,097 $ 210,078
Royalty      
Revenue      
Total revenue 8,276 6,367 4,686
Licensing      
Revenue      
Total revenue $ 750 $ 1,774 $ 239